Fierce Biotech: Septerna emerges with $100M to spark ‘second golden age’ of prolific drug target GPCR with pioneer as co-founder Read more https://www.fiercebiotech.com/biotech/septerna-emerges-100m-to-spark-second-golden-age-most-prolific-drug-target-gpcr-pioneer-bob
